Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$25.86 - $46.71 $101,241 - $182,869
-3,915 Reduced 49.08%
4,062 $188,000
Q1 2023

Apr 27, 2023

BUY
$26.05 - $32.31 $103,131 - $127,915
3,959 Added 98.53%
7,977 $228,000
Q4 2022

Feb 02, 2023

BUY
$19.77 - $42.23 $79,435 - $169,680
4,018 New
4,018 $125,000
Q2 2022

Aug 03, 2022

SELL
$13.19 - $22.1 $47,035 - $78,808
-3,566 Reduced 32.89%
7,277 $112,000
Q1 2022

May 02, 2022

BUY
$14.54 - $25.02 $157,657 - $271,291
10,843 New
10,843 $207,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.